Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Payables (2010 - 2026)

Vericel (VCEL) posted Payables of $20.6 million for Q2 2026, up 8.44% sequentially from $19.0 million in Q1 2026, and up 60.33% YoY from $12.9 million in Q2 2025.

Analysis

Vericel (VCEL) Payables (2010 - 2026) Analysis & Trends

Vericel has reported Payables for 17 years, with the latest figure at $20.6 million in Q2 2026.

  • Quarterly Payables rose 60.33% year-over-year to $20.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.6 million (up 60.33% YoY) and the FY2025 annual result came in at $15.8 million, down 33.63% from the prior year.
  • Payables rose to $20.6 million in Q2 2026 per VCEL's latest filing, from $19.0 million in the prior quarter.
  • Over five years, Payables peaked at $25.2 million in Q2 2024 and troughed at $7.8 million in Q1 2022.
  • A 5-year average of $16.4 million and a median of $16.3 million in 2025 frame the typical range for Payables.
  • The sharpest annual moves came in 2022 and 2025: Payables jumped 87.78% in 2022, then tumbled 49.01% in 2025.
  • Over 5 years, Payables stood at $16.9 million in 2022, then surged by 32.0% to $22.3 million in 2023, then climbed by 6.72% to $23.8 million in 2024, then tumbled by 33.63% to $15.8 million in 2025, then soared by 30.24% to $20.6 million in 2026.
  • According to Business Quant data, Payables over the past three periods registered $20.6 million, $19.0 million, and $15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 20.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.61 Mn
Mar 31, 2026 19.01 Mn
Dec 31, 2025 15.83 Mn
Sep 30, 2025 15.34 Mn
Jun 30, 2025 12.86 Mn
Mar 31, 2025 16.75 Mn
Dec 31, 2024 23.85 Mn
Sep 30, 2024 20.88 Mn
Jun 30, 2024 25.22 Mn
Mar 31, 2024 19.43 Mn
Dec 31, 2023 22.35 Mn
Sep 30, 2023 15.05 Mn
Jun 30, 2023 14.40 Mn
Mar 31, 2023 11.13 Mn
Dec 31, 2022 16.93 Mn
Sep 30, 2022 8.11 Mn
Jun 30, 2022 9.68 Mn
Mar 31, 2022 7.75 Mn
Dec 31, 2021 9.02 Mn
Sep 30, 2021 5.58 Mn